Personalis (PSNL) Income from Continuing Operations (2018 - 2026)
Personalis (PSNL) posted quarterly Income from Continuing Operations of 30032000.0 for Q1 2026, down 90.68% year-over-year from 322209809.26 in Q1 2025, and down 152.21% on a QoQ basis from 57521000.0 in Q4 2025.
Personalis (PSNL) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Personalis (PSNL) has reported Income from Continuing Operations for 9 consecutive years, with 30032000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 90.68% year-over-year to 30032000.0; the TTM figure through Mar 2026 stood at 14219000.0 (up 83.09% YoY), while the FY2025 annual figure was 63000.0, up 100.08% from the prior year.
- Income from Continuing Operations came in at 30032000.0 for Q1 2026 at Personalis, down from 57521000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 82490000.0 in Q4 2022, with the low at 39089000.0 in Q3 2024.
- Average Income from Continuing Operations over 5 years is 12900352.94, with a median of 23955000.0 recorded in 2023.
- Across the five-year window, Income from Continuing Operations surged 503.75% in 2022 and slumped 132.23% in 2023, its largest moves.
- Year by year, Income from Continuing Operations stood at 82490000.0 in 2022, then plunged by 132.23% to 26584000.0 in 2023, then jumped by 38.21% to 16425000.0 in 2024, then surged by 450.2% to 57521000.0 in 2025, then tumbled by 152.21% to 30032000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 30032000.0, 57521000.0, and 21652000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Personalis | 1.44 Bn | 1.20 Bn | 281,000.00 | -30.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.03 Mn |
| Dec 31, 2025 | 57.52 Mn |
| Sep 30, 2025 | -21.65 Mn |
| Jun 30, 2025 | -20.06 Mn |
| Mar 31, 2025 | -15.75 Mn |
| Dec 31, 2024 | -16.43 Mn |
| Sep 30, 2024 | -39.09 Mn |
| Jun 30, 2024 | -12.80 Mn |
| Mar 31, 2024 | -12.97 Mn |
| Dec 31, 2023 | -26.58 Mn |
| Sep 30, 2023 | -29.10 Mn |
| Jun 30, 2023 | -23.96 Mn |
| Mar 31, 2023 | -28.66 Mn |
| Dec 31, 2022 | 82.49 Mn |
| Sep 30, 2022 | -26.49 Mn |
| Jun 30, 2022 | -27.55 Mn |
| Mar 31, 2022 | -28.21 Mn |
| Dec 31, 2021 | -20.43 Mn |
| Sep 30, 2021 | -17.67 Mn |
| Jun 30, 2021 | -14.95 Mn |